COVID-19 and diabetes mellitus: from pathophysiology to clinical management
Initial studies found increased severity of coronavirus disease 2019 (COVID-19), caused by
infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in patients …
infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in patients …
COVID-19: characteristics and therapeutics
R Chilamakuri, S Agarwal - Cells, 2021 - mdpi.com
Novel coronavirus (COVID-19 or 2019-nCoV or SARS-CoV-2), which suddenly emerged in
December 2019 is still haunting the entire human race and has affected not only the …
December 2019 is still haunting the entire human race and has affected not only the …
JAK-STAT pathway inhibition and their implications in COVID-19 therapy
S Satarker, AA Tom, RA Shaji, A Alosious… - Postgraduate …, 2021 - Taylor & Francis
As the incidence of COVID-19 increases with time, more and more efforts are made to pave
a way out for the therapeutic strategies to deal with the disease progression. Inflammation …
a way out for the therapeutic strategies to deal with the disease progression. Inflammation …
COVID-19 drugs in aquatic systems: a review
The outbreak of the human coronavirus disease 2019 (COVID-19) has induced an
unprecedented increase in the use of several old and repurposed therapeutic drugs such as …
unprecedented increase in the use of several old and repurposed therapeutic drugs such as …
[HTML][HTML] Deaths induced by compassionate use of hydroxychloroquine during the first COVID-19 wave: an estimate
A Pradelle, S Mainbourg, S Provencher… - Biomedicine & …, 2024 - Elsevier
Background During the first wave of COVID-19, hydroxychloroquine (HCQ) was used off-
label despite the absence of evidence documenting its clinical benefits. Since then, a meta …
label despite the absence of evidence documenting its clinical benefits. Since then, a meta …
Interleukin-6 perpetrator of the COVID-19 cytokine storm
J Shekhawat, K Gauba, S Gupta, P Purohit… - Indian Journal of Clinical …, 2021 - Springer
COVID-19 has emerged as a global pandemic. It is mainly manifested as pneumonia which
may deteriorate into severe respiratory failure. The major hallmark of the disease is the …
may deteriorate into severe respiratory failure. The major hallmark of the disease is the …
An update on antiviral therapy against SARS-CoV-2: how far have we come?
O Indari, S Jakhmola, E Manivannan… - Frontiers in …, 2021 - frontiersin.org
COVID-19 pandemic has spread worldwide at an exponential rate affecting millions of
people instantaneously. Currently, various drugs are under investigation to treat an …
people instantaneously. Currently, various drugs are under investigation to treat an …
Involvement of the nervous system in COVID-19: The bell should toll in the brain
S Satarker, M Nampoothiri - Life sciences, 2020 - Elsevier
The world is fuming at SARS-CoV-2 for being the culprit for causing the devastating COVID-
19, claiming millions of lives across the globe in the form of respiratory disorders. But lesser …
19, claiming millions of lives across the globe in the form of respiratory disorders. But lesser …
A multi-targeting drug design strategy for identifying potent anti-SARS-CoV-2 inhibitors
The COVID-19, caused by SARS-CoV-2, is threatening public health, and there is no
effective treatment. In this study, we have implemented a multi-targeted anti-viral drug …
effective treatment. In this study, we have implemented a multi-targeted anti-viral drug …
[HTML][HTML] Prevention and treatment of COVID-19: Focus on interferons, chloroquine/hydroxychloroquine, azithromycin, and vaccine
The ongoing pandemic caused by the severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) has drawn the attention of researchers and clinicians from several disciplines …
(SARS-CoV-2) has drawn the attention of researchers and clinicians from several disciplines …